Abstract
Several patterns of maladaptive behaviors share their clinical features with those of substance use disorders such as tolerance, withdrawal, repeated unsuccessful attempts to cut back or quit, and interference in major areas of life function, thus gaining the name of “behavioral addictions”. Several studies showed that behavioral addictions and substance addictions share a similar pattern of brain activation during symptom provocation tasks, suggesting a common neurobiological substrate. However, despite the growing knowledge on the neurobiological underpinnings of behavioral addictions, treatment of these conditions is still controversial. Research Domain Criteria project would help in identifying circuitry involved in complex behavioral syndromes such as addiction either to substances or not-substances. The purpose of this review is to summarize current knowledge of the different pharmacological approaches to behavioral addictions. In particular, we will focus on the pharmacological treatment of pathological gambling, internet addiction and hypersexual disorder.
Keywords: Addictions, hypersexual disorder, maladaptive behaviors, pathological gambling.
Current Psychopharmacology
Title:Pharmacological Treatments for Behavioral Addictions: From Behavioral Dimensions to the Research Domain Criteria Based Target
Volume: 2
Author(s): Stefano Pallanti, Giacomo Grassi, Tommaso Tofani and Silvia Spitoni
Affiliation:
Keywords: Addictions, hypersexual disorder, maladaptive behaviors, pathological gambling.
Abstract: Several patterns of maladaptive behaviors share their clinical features with those of substance use disorders such as tolerance, withdrawal, repeated unsuccessful attempts to cut back or quit, and interference in major areas of life function, thus gaining the name of “behavioral addictions”. Several studies showed that behavioral addictions and substance addictions share a similar pattern of brain activation during symptom provocation tasks, suggesting a common neurobiological substrate. However, despite the growing knowledge on the neurobiological underpinnings of behavioral addictions, treatment of these conditions is still controversial. Research Domain Criteria project would help in identifying circuitry involved in complex behavioral syndromes such as addiction either to substances or not-substances. The purpose of this review is to summarize current knowledge of the different pharmacological approaches to behavioral addictions. In particular, we will focus on the pharmacological treatment of pathological gambling, internet addiction and hypersexual disorder.
Export Options
About this article
Cite this article as:
Pallanti Stefano, Grassi Giacomo, Tofani Tommaso and Spitoni Silvia, Pharmacological Treatments for Behavioral Addictions: From Behavioral Dimensions to the Research Domain Criteria Based Target, Current Psychopharmacology 2013; 2 (3) . https://dx.doi.org/10.2174/22115560113029990002
DOI https://dx.doi.org/10.2174/22115560113029990002 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Therapeutic Strategies in Major Depression: Focus on RNAi and Ketamine
Current Pharmaceutical Design Amyloid PET and MRI in Alzheimers Disease and Mild Cognitive Impairment
Current Alzheimer Research Dipyridamole: A Drug with Unrecognized Antioxidant Activity
Current Topics in Medicinal Chemistry Reward-Seeking Behavior and Addiction: Cause or Cog?
Current Drug Abuse Reviews Pharmacokinetics and Acute Toxicity of a Histone Deacetylase Inhibitor, Scriptaid, and its Neuroprotective Effects in Mice After Intracranial Hemorrhage
CNS & Neurological Disorders - Drug Targets Brain Metabolism of Ethanol and Alcoholism: An Update
Current Drug Metabolism Therapeutic Efficacy of Selegiline in Neurodegenerative Disorders and Neurological Diseases
Current Drug Targets Early Hematoma Enlargement in Primary Intracerebral Hemorrhage
Current Drug Targets Triggers and Anatomical Substrates in the Genesis and Perpetuation of Atrial Fibrillation
Current Cardiology Reviews New Pharmacological Approaches in Infants with Hypoxic-Ischemic Encephalopathy
Current Pharmaceutical Design “Speed” Warps Time: Methamphetamines Interactive Roles in Drug Abuse, Habit Formation, and the Biological Clocks of Circadian and Interval Timing
Current Drug Abuse Reviews Non-Amyloid PET Imaging Biomarkers for Neurodegeneration: Focus on Tau, Alpha-Synuclein and Neuroinflammation
Current Alzheimer Research Thioridazine: The Good and the Bad
Recent Patents on Anti-Infective Drug Discovery Incretin Analogues that have been Developed to Treat Type 2 Diabetes Hold Promise as a Novel Treatment Strategy for Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Future Perspectives on the Fibrinolytic Therapy of Intracerebral Hemorrhages
Central Nervous System Agents in Medicinal Chemistry Vascular Risk Factors and Neurodegeneration in Ageing Related Dementias: Alzheimer’s Disease and Vascular Dementia
Current Alzheimer Research The Role of Oxidative Stress in Huntington’s Disease: Are Antioxidants Good Therapeutic Candidates?
Current Drug Targets Decreased Plasma Level of Lipoprotein Lipase Predicted Verbal Disfluency in Chinese Type 2 Diabetes Mellitus Patients with Early Cognitive Deficits
Current Alzheimer Research Glutamate and Mitochondria: Two Prominent Players in the Oxidative Stress-Induced Neurodegeneration
Current Alzheimer Research Clinical Applications of Positron Emission Tomography (PET) Imaging in Medicine: Oncology, Brain Diseases and Cardiology
Current Radiopharmaceuticals